论文部分内容阅读
静脉溶栓是治疗急性心肌梗死的一个经典、疗效确切的方法,但是有些病人有溶栓的禁忌症或者失去溶栓的时机,并且有溶栓失败、再闭塞的可能,这使得该方法具有一定的局限性。而随着介入治疗技术的迅猛发展,有学者提出直接经皮介入冠状动脉内血管成形术(primay PTCA)优于静脉溶栓治疗。如何正确认识及选择恰当的治疗方法,为回答这个问题,我们摘译了Cochrane图书馆中比较直接血管成形术与静脉溶栓治疗急性心肌梗死的随机对照试验的Cochrane系统评估文献。
Intravenous thrombolysis is a classic and curative approach for the treatment of acute myocardial infarction, but some patients have contraindications to thrombolysis or the timing of thrombolysis and the failure of thrombolysis and the possibility of reocclusion, making this method a definite Limitations. With the rapid development of interventional therapy, some scholars have proposed that direct percutaneous coronary angioplasty (primay PTCA) is superior to intravenous thrombolysis. To answer this question correctly, and how to correctly understand and choose the appropriate treatment, we cite the Cochrane systematic review of randomized controlled trials of the Cochrane Library for the treatment of acute myocardial infarction with direct angioplasty and intravenous thrombolysis.